Average Foreign Price Adjustment Results in NHI Price Lower than Manufacturing Cost for Pfizer Japan’s Tygacil: CSIMC

Members of the Central Social Insurance Medical Council (CSIMC) discussed NHI pricing of the antibacterial agent Tygacil Injection 50 mg (tigecycline; Pfizer Japan) at a general assembly on November 14. A number of members raised questions in the face of...read more